Page 89 - Annual Report 2021

7. inVEstMEnts in assOciatEs
the company
2021 2020
rM rM
Unquoted shares, at cost 1,653,205 1,653,205
Share of post-acquisition losses (1,434,833) (1,434,833)
Impairment loss (90,715) (90,715)
127,657 127,657

The details of the associates, which are incorporated in Malaysia, are as follows:-

Effective Equity
name of associate interest Principal activities
2021 2020
% %
Held through uMcB, or via its nominees:-

Nanobio Sdn. Bhd.^* 70 70 Dormant.

Zecttron Sdn. Bhd. ^* 70 70 Conduct training programme.

UM Business Sdn. Bhd. ^* 100 100 Research and development.

CBMTI Sdn. Bhd.^ 33 33 Medical technology.

Cytus Sdn. Bhd.^ 33 33 Cell Biobank.

Granatech Sdn. Bhd.^* 70 70 Research contract, consultation,
production of tissue culture plants.

UMCH Technology Sdn. Bhd.^ 30 30 Predictive information systems and
telemonitoring systems.

Bioapps Sdn. Bhd.^ 20 20 Medical equipment and consumable
medical product supplier.

Flexilicate Sdn. Bhd.^ 49 49 Optical fiber design, fabrication and
trading.

Fylix Sdn. Bhd. 20 20 Commercialise optical splitter.

Annual Report 2021 89